Danny Robert Hegglin

TT International (Hong Kong) Ltd. (TT-Hong Kong) is the alternative investment management subsidiary of Great Britain-based TT International Asset Management Ltd., which was acquired in 2020 by Sumitomo Mitsui Financial Group, Inc. (TYO: 8316) in Japan. Headquartered in Hong Kong, TT-Hong Kong was founded in 2004 to manage long/short Asian equities and hedge fund products, primarily for sophisticated institutional investors.

Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.